[DOC] Genetic Polymorphisms and Susceptibility to Parenchymal ... - PLOS,https://journals.plos.org/plosone/article/file%3Ftype%3Dsupplementary%26id%3Dinfo:doi/10.1371/journal.pone.0140128.s002
[DOC] Not elite athletes (n = 9) - PLOS,https://journals.plos.org/plosone/article/file%3Ftype%3Dsupplementary%26id%3D10.1371/journal.pone.0217390.s001
[DOC] ZIP-Document - MDPI,https://www.mdpi.com/1999-4915/10/9/462/s1
[DOC] The maintenance of shared visible polymorphisms by frequency ...,http://eprints.whiterose.ac.uk/123749/1/Accepted_Version_v_36.docx
[DOC] https://links.lww.com/MD/E311,https://links.lww.com/MD/E311
[DOC] mmc1.docx - Multiple Sclerosis and Related Disorders,https://www.msard-journal.com/cms/10.1016/j.msard.2022.103834/attachment/1b471bc1-83c1-486a-a280-ce27669cb096/mmc1.docx
[DOC] 69868s1.docx - International Journal of Medical Sciences,https://www.medsci.org/ms/doc/2189/epub/69868s1/69868s1.docx
[DOC] mmc1.docx,https://www.cell.com/cms/10.1016/j.tig.2020.08.003/attachment/79f1df4d-948f-41bf-b3ca-1f35de29bd04/mmc1.docx
"[DOC] November, 2017 - Oregon.gov",https://www.oregon.gov/oha/HPA/DSI-HERC/SearchablePLdocuments/GL-173-CPT-81232-81246-5-fluorouracil-5-FU-capecitabine-drug-metabolism.docx
[DOC] manuscript.docx - Research Square,https://assets.researchsquare.com/files/rs-33439/v2/manuscript.docx
